We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Time for truth

7 December 2016 By Robert Cyran

The U.S. president-elect said he dislikes what has happened to drug prices, and pharma stocks slumped. Hillary Clinton’s views once carried similar weight. That’s because the jabs are justified. Investors know there’s too little innovation and too much reliance on raising prices.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)